Skip to main content

Dr. Agbor is a Lasker Clinical Research Tenure-Track Investigator and Chief of Laboratory of Applied Precision Omics at NHLBI, with a joint appointment at Johns Hopkins. His research addresses gaps that contribute to poor transplant outcomes. He showed that cell-free DNA detects transplant rejection 2 – 4 months earlier than histopathology, setting the stage for clinical trials/research consortia that he leads, including Genomic Research Alliance for Transplantation (GRAfT), COVID-19 Injury Map and others. He is developing additional cell-free DNA approaches with broad applicability in transplant and non-transplant conditions.

Leave a Reply